Evidence map›Paper›PMID 33318020›Full record

ArticleAntimicrobial agents and chemotherapy2021

BKC-2, a New BKC Variant Detected in MCR-9.1-Producing Enterobacter hormaechei subsp.

Willames M B S Martins, Evelin R Martins, Letícia K de Andrade, Refath Farzana, Timothy R Walsh, Mark A Toleman, Mara C L Nogueira, Ana C Gales

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Willames M B S Martins *Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina/Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil willamesbrasileiro@hotmail.com ml.nogueira@famerp.br ana.gales@gmail.com.ORCID 0000-0002-3001-3625
Evelin R Martins *Centro de Investigação de Microrganismos, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.
Letícia K de AndradeCentro de Investigação de Microrganismos, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.
Refath FarzanaDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Timothy R WalshDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Mark A TolemanDepartment of Medical Microbiology, Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom.
Mara C L NogueiraCentro de Investigação de Microrganismos, Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil willamesbrasileiro@hotmail.com ml.nogueira@famerp.br ana.gales@gmail.com.
Ana C GalesDivision of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina/Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil willamesbrasileiro@hotmail.com ml.nogueira@famerp.br ana.gales@gmail.com.
Cardiff University · GBFaculdade de Medicina de São José do Rio Preto · BRUniversidade Federal de São Paulo · BRUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We characterized a multidrug-resistant (MDR)

Indexed as

ColistinEnterobacterAnti-Bacterial Agentsbeta-LactamasesBrazilHumansPlasmidsAnti-Bacterial Agentsbeta-LactamasesColistinantimicrobial resistancecarbapenemasephosphoethanolamine transferaseplasmids

Identifiers

PMID33318020
PMCPMC8092528
OpenAlexW3111478081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.